Prostate Cancer Screening: The Conversation to Have

Visit Prostate cancer is the most common cancer among men in Canada after non-melanoma skin cancers [1]. However, there is no systematic program screening. The reason: the’prostate-specific antigen (PSA) has its limitations, and the benefits outweigh the drawbacks only in certain profiles. This article explains why the decision is a personal one, who should discuss it sooner rather than later, how screening works, and when to seek medical attention immediately.

On this page

• Why isn't there a systematic program?
• Shared Discussion: With Whom and at What Age
• How Does Screening Work?
• Interpreting a High APS
• When to Seek Care Immediately Without Screening
• Living with a Diagnosis of Prostate Cancer
• Prevention and Lifestyle
• Myths and Misconceptions
• Frequently asked questions
• Sources

Why isn't there a systematic program?

Unlike breast cancer or colorectal cancer, there is no Quebec program prostate cancer screening. There are several reasons for this position [1][2].

The Limitations of APS as a Screening Test

• The Test APS also detects cancers indolent that would never have caused any problems during the patient's lifetime
• Visit overdiagnosis leads to biopsies and treatments (incontinence, erectile dysfunction, urinary disorders) that are sometimes unnecessary
• APS can be high non-cancerous (benign enlargement, prostatitis, recent ejaculation, exercise)
• Visit profits The effects on overall mortality are modest in randomized trials
• Visit Canadian Study Group on preventive health care advises against routine screening [2]
• Visit recommendations have evolved over the past two decades, shifting from widespread screening to an individualized approach

Key Takeaways

• Screening for Prostate cancer is not standard practice in Quebec: it is a joint decision between a patient and his doctor [2]
• Visit discussion is recommended between the ages of 50 and 70, or earlier (at age 45) in cases of increased risk (family history, African ancestry, BRCA1/2 mutations)
• L’APS is a useful but imperfect tool: it can be elevated in the absence of cancer (benign hypertrophy, prostatitis), and some indolent cancers do not require treatment
• L’MRI Prostate screening prior to biopsy has reduced the number of unnecessary biopsies and improved the detection of clinically significant cancers
• From lower urinary tract symptoms, hematuria, bone pain, or unexplained weight loss are reasons to seek medical attention, regardless of screening
• Visit lifestyle (physical activity, a balanced diet, a healthy weight, and not smoking) contributes to prostate and overall health

Shared Discussion: With Whom and at What Age

Most professional societies (Canadian Urological Association, NCCN, EAU) recommend a patient-doctor discussion between 50 and 70 years old to assess the appropriateness of screening [1][3].

Higher-risk groups (discussed earlier, starting at age 45)

• Family history prostate cancer (father, brother)
• Ancestral African origins (documented higher risk)
• BRCA1/BRCA2 Mutations or Lynch syndrome
• A family history of breast or ovarian cancer
• Prostate Cancer multiple within the family (more than one first-degree relative)
• The presence of several cumulative factors

What the discussion should cover

• Visit potential benefits screening (early detection of aggressive cancers)
• Visit potential drawbacks (false positives, unnecessary biopsies, overdiagnosis, overtreatment, anxiety, side effects of treatments)
• Visit personal profile risk factors (age, family history, ethnicity, comorbidities)
• L’life expectancy overall health and general well-being
• Visit preferences and the patient's values
• Terms and Conditions concrete screening, if chosen (frequency, interpretation guidelines, follow-up)
• The possibility of change one's mind during follow-up

When Screening Is Generally Not Recommended

• Life expectancy less than 10 to 15 years due to age or severe comorbidities
• Men > 70 years old without any specific risk factors, unless there is an explicit shared decision
• Already a man diagnosed or follow-up care for prostate cancer
• Informed refusal after discussion on the pros and cons

How Does Screening Work?

Typical Steps

• Serum APS — a simple blood test; fasting or non-fasting, depending on the laboratory
• Rectal examination — Not effective on its own, but more useful when combined with APS; it helps assess the consistency of the prostate
• Stratification risk based on the outcome and the context (age, medical history, rate of APS progression over time)
• If High APS : repeat, sometimes a prostate MRI before biopsy, guided biopsy
• Discussion on the consequences depending on the result
• Scheduling of inspections further tests if a decision is made to continue screening

Before the APS test

• Avoid ejaculation within the previous 48 hours (may temporarily raise the APS)
• Avoid intense physical activity (especially cycling) the day before the test
• Inform your doctor about any recent urinary tract infections or current urinary symptoms
• Inform your doctor about the medications you are taking (certain 5-alpha-reductase inhibitors, such as finasteride and dutasteride, can lower APS)
• Discuss coordinate with your doctor to avoid bias

Test Frequency

• If a screening decision is made: for 2- to 4-year-olds based on the risk profile and the base value
• A Basic APS very low At age 50, this is reassuring and can allow for longer intervals between tests
• An APS in progression A rapid or high rate warrants closer monitoring
• L’stop Screening options are discussed based on age and overall health
• Visit recommendations The exact figures vary depending on the professional organizations; consulting with a doctor allows for a personalized approach

Are you 50 or older and wondering about screening? Omicron Clinic offers a structured discussion about prostate cancer screening at our locations in Quebec, with the option of a teleconsultation to begin the discussion. Make an appointment or opt for the teleconsultation.

Interpreting a High APS

A high APS does not mean not does not automatically mean cancer. There are several possible causes for an elevated level.

Causes of Elevated APS Levels

• Benign Hypertrophy benign prostatic hyperplasia (BPH) — very common after age 50
• Prostatitis acute or chronic
• Cancer prostate
• Urinary tract infection recent
• Manipulation recent prostate examination (recent digital rectal exam, biopsy, cystoscopy)
• Ejaculation recent
• Intense exercise (cycling)
• Variations normal, depending on the laboratory and the technique

What to Do If Your APS Is High

• Repeat a follow-up blood test (4 to 6 weeks later)
• Delete transient causes (infection, recent handling)
• Consider a Free APS (free APS to total APS ratio), which can help refine the interpretation
• Prostate MRI Multiparametric imaging, if available, prior to biopsy: improves the detection of clinically significant cancers and avoids unnecessary biopsies
• Orientation to the urology department for further treatment
• Decision of biopsy based on the MRI results (PI-RADS score), the progression of PSA, and the risk profile
• Biopsy guided by MRI or transrectal ultrasound, depending on the center

What to Do After a Confirmed Diagnosis

• Characterization Cancer: Gleason score, stage, local and distant spread
• Review of’extension if necessary (CT scan, bone scan, MRI, PSMA-PET in some cases)
• Presentation in multidisciplinary committee at several locations
• Choosing the strategy Depending on the risk: active surveillance, surgery, radiation therapy, hormone therapy, targeted therapies
• Active Monitoring often preferred for low-risk cancers, to avoid overtreatment
• Support Psychological support and counseling

When to Seek Care Immediately Without Screening

Some symptoms warrant a medical consultation, even in the absence of a scheduled screening.

Lower Urinary Tract Symptoms

• Weak spray, difficulty starting to urinate
• Nocturia (getting up at night to urinate) unusual
• Emergencies urinary
• Feeling of incomplete drain
• Frequent urination (urinating more often in small amounts)
• Difficulty to begin urination
• More rarely: Pain during urination (often associated with an infection)

Warning Signs You Shouldn't Ignore

• Hematuria (blood in the urine), even a single episode
• Hematospermia (blood in the semen), especially after age 40
• Bone pain unexplained, particularly in the lower back, pelvis, and hips
• Weight loss unexplained
• Fatigue significant and new
• Edema to the lower limbs
• Erectile dysfunction new cases with other symptoms

Differential Diagnosis to Keep in Mind

• L’benign hypertrophy Prostate cancer causes lower urinary tract symptoms in many men
• Visit prostatitis may cause pain and urinary symptoms
• Visit bladder cancer may present as hematuria
• Visit Urinary tract infections, particularly in men, warrant a comprehensive evaluation
• A medical evaluation helps distinguish between these causes and guide treatment

Living with a Diagnosis of Prostate Cancer

Treatment Strategies Based on Risk

• Active Monitoring : Regular follow-up (APS, MRI, follow-up biopsies) for low-risk cancers that do not require immediate treatment
• Surgery (radical prostatectomy), sometimes robot-assisted
• External Beam Radiation Therapy or brachytherapy
• Hormone therapy (androgen deprivation)
• Targeted Treatments and new drugs for advanced stages (in specialized care settings)
• Combinations based on the profile Cancer and the Patient
• Choices discussed as part of a multidisciplinary team

Possible Side Effects

• Erectile dysfunction (surgery, radiation therapy, hormone therapy)
• Urinary incontinence (especially surgery)
• Intestinal Disorders (radiation therapy)
• Hot flashes, decreased libido, physical changes (hormone therapy)
• Fatigue, anxiety, depression
• Impacts on relationships and sexuality
• Support through perineal physical therapy, psychology, sexology, and support groups

Support Resources

• Breast and Prostate Cancer: Procure and other specialized organizations
• Canadian Cancer Society : information, support groups, helpline 1-888-939-3333
• Support For family caregivers: 1-855-852-7784
• Health Info 811, option 1 and Info-Social 811, option 2
• In case of distress : 1-866 CALL (1-866-277-3553)
• Social worker from the CLSC or the hospital for administrative procedures
• Sexologist and physical therapist in pelvic health for sexual and urinary complications

Prevention and Lifestyle

There is no method guarantee to prevent prostate cancer, but several habits contribute to prostate and overall health.

Habits That Can Help

• Physical Activity regular (at least 150 minutes of moderate-intensity activity per week)
• Power supply balanced, rich in vegetables, fruits, legumes, and fatty fish
• Maintain a healthy weight
• Limit red meat and deli meats
• No Smoking or quit smoking
• Consume Alcohol in moderation
• Prioritize fats healthy (olive oil, nuts, avocado)
• Balance sheet Regular health checkups after age 40

Supplements and «miracle» foods: the nuances

• Lycopene (tomatoes), omega-3, green tea : moderate evidence; incorporate into a balanced diet
• Vitamin D : depending on the context and after evaluation
• Selenium and Vitamin E Additionally: no proven benefit for the prevention of prostate cancer, and possible risks
• No supplement has not demonstrated clear efficacy in primary prevention
• Talk to your doctor before taking any supplements

Myths and Misconceptions

«All men should undergo an APS starting at age 40»

False. APS Screening for Men medium risk Screening before age 50 is not recommended: the risk of clinically significant cancer is low, and the risk of overdiagnosis is high. Men at increased risk may discuss this starting at age 45.

«A normal APS means zero risk»

False. An APS in the standard is reassuring but does not completely rule out prostate cancer. That is why we combine the PSA test, a digital rectal exam, changes over time, medical history, and symptoms to assess the overall risk.

«A biopsy always follows an elevated APS»

False. Several steps Prior to the biopsy: confirmation through a second test, ruling out transient causes (infection, handling), and sometimes a prostate MRI. Many men with elevated PSA levels will never undergo a biopsy.

«Prostate cancer is always serious.»

False. Many cases of prostate cancer are slow progress and can be monitored without immediate treatment (active surveillance). Others are indeed aggressive and warrant active treatment. The prognosis depends on the Gleason score, the stage, and the patient’s overall condition.

«The treatment inevitably leads to impotence.»

Not always. Visit side effects vary depending on the treatment, age, baseline sexual function, and the techniques used. The modern techniques (nerve-sparing surgery, targeted radiation therapy) have reduced long-term effects. A preliminary discussion and ongoing support (perineal physical therapy, treatments for erectile dysfunction, sex therapy) help optimize recovery.

Frequently asked questions

At what age should I start discussing screening with my doctor?

For most men: between 50 and 70 years old. Earlier (45 years old) in cases of increased risk: direct family history (father, brother), African ancestry, BRCA1/2 mutations, or Lynch syndrome. Screening is generally not recommended for men whose life expectancy is less than 10 to 15 years due to age or severe comorbidities.

Is the APS test covered by RAMQ?

L’APS is generally covered by the RAMQ when prescribed in a clinically justified context (symptoms, medical history, follow-up). For a simple screening In the absence of specific symptoms or risk factors, the patient may be responsible for the cost in certain situations. Check with your doctor and pharmacist depending on the situation.

Is a digital rectal exam really necessary?

A digital rectal exam alone is not Most Recommended as a screening test. However, it still plays a role in addition from the APS and during the assessment of symptoms. Certain abnormalities (hard nodules, irregularities) cannot be detected by the APS alone. The decision is made on a case-by-case basis with the doctor.

What are the risks of a prostate biopsy?

Visit biopsies are generally well tolerated but carry some risks: urinary tract or prostate infection, blood in the urine, semen, or stool for a few days to a few weeks; urinary retention is less common. Antibiotic prophylaxis is standard practice. The use of MRI before a biopsy can help avoid the need for a biopsy in some patients and target suspicious areas in others.

What is active surveillance?

Visit active monitoring is a strategy used for low-risk prostate cancers : Treatment is not initiated immediately, but the patient is monitored regularly (APS, physical exams, MRI scans, follow-up biopsies). If the cancer remains stable, the patient avoids the side effects of treatment. If the disease progresses, curative treatment remains an option. This approach is preferred to avoid overtreatment.

My father had prostate cancer. What is my risk?

A direct family history (father, brother) increases the risk (approximately 2 to 3 times, depending on the number of affected relatives and the age at diagnosis). A discussion about screening is generally recommended ages 45 and up. If there are multiple cases in the family, or cases of breast or ovarian cancer in the family, a genetic consultation may be appropriate.

Sources

1. Canadian Association of Urologists (CAU). Guidelines on Prostate Cancer Screening Using APS.
2. Canadian Task Force on Preventive Health Care. Recommendations on Prostate Cancer Screening.
3. Canadian Cancer Society. Prostate Cancer: Information and Screening.
4. INESSS — National Institute for Excellence in Health and Social Services. Information and Guides on Prostate Cancer in Quebec.
5. European Association of Urology (EAU). Guidelines on Prostate Cancer.
6. National Comprehensive Cancer Network (NCCN). Guidelines for the Early Detection of Prostate Cancer.
7. Procure — Prostate Cancer. Patient Information and Support in Quebec.

Medical consultation | Clinique Omicron